Synthonics
Blacksburg, US
Synthonics develops Metal Coordination Pharmaceuticals (MCPs), which chelate metal ions to known drugs to improve properties such as absorption, efficacy, and onset of action. The company holds four US patents for its MCP technologies and works in the pharmaceutical and biotech industry.
Founders & leadership
Board
JB
john borlingBoard director
SP
scott palmerBoard director
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2014
▶$500KraisedJul 2014 · 5 investors · BiotechnologyRule 506(c)
▶$500KraisedJul 2014 · 5 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- thomas piccarielloExecutive Officer, Director
- john borlingDirector
- scott palmerDirector
- kenneth j slepickaExecutive Officer, Director
- john tinkhamExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $500K
- Minimum investment
- $10K
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Synthonics do?
- Synthonics develops Metal Coordination Pharmaceuticals (MCPs), which chelate metal ions to known drugs to improve properties such as absorption, efficacy, and onset of action. The company holds four US patents for its MCP technologies and works in the pharmaceutical and biotech industry.
- Who founded Synthonics?
- Synthonics was founded by thomas piccariello.
- How much funding has Synthonics raised?
- Synthonics has disclosed $500K raised across 1 round.
- Where is Synthonics headquartered?
- Synthonics is headquartered in Blacksburg, US.